Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
Fish and Richardson
Healthtrust
Covington
Cerilliant
Johnson and Johnson
Cipla
Chinese Patent Office

Generated: May 20, 2018

DrugPatentWatch Database Preview

BREVITAL SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Brevital Sodium, and what generic alternatives are available?

Brevital Sodium is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methohexital sodium profile page.
Drug patent expirations by year for BREVITAL SODIUM
Pharmacology for BREVITAL SODIUM
Ingredient-typeBarbiturates
Drug ClassBarbiturate
Medical Subject Heading (MeSH) Categories for BREVITAL SODIUM
Synonyms for BREVITAL SODIUM
.alpha.-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid
(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid
1-methyl-5-(1-methyl-2-pentynyl)-5-allyl-barbituric acid
1-methyl-5-(1-methylpent-2-yn-1-yl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
1-methyl-5-(1-methylpent-2-yn-1-yl)-5-prop-2-en-1-ylpyrimidine-2,4,6(1H,3H,5H)-trione
1-methyl-5-(1-methylpent-2-ynyl)-5-prop-2-enyl-hexahydropyrimidine-2,4,6-trione
1-Methyl-5-allyl-5-(1-methyl-2-pentynyl)barbituric acid sodium salt
115621-33-5
151-83-7
18652-93-2
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (.+/-.)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (+-)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (+-)-, monosodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, sodium salt
2,4,6(1H,3H,5H)-PYRIMIDINETRIONE,1-METHYL-5-(1-METHYL-2-PENTYN-1-YL)-5-(2-PROPEN-1-YL)-
22151-68-4
309-36-4
32671-83-3
33975-80-3
5-(hex-3-yn-2-yl)-1-methyl-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione
5-(hex-3-yn-2-yl)-6-hydroxy-3-methyl-5-(prop-2-en-1-yl)-2,3,4,5-tetrahydropyrimidine-2,4-dione
5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid sodium salt
5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione
5-allyl-1-methyl-5-(1-methylpent-2-ynyl)hexahydropyrimidine-2,4,6-trione
5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid
5-allyl-5-(hex-3-yn-2-yl)-1-methylpyrimidine-2,4,6(1h,3h,5h)-trione
5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
60634-69-7
7187-72-6
a-dl-1-methyl-5-(1-methyl-2-pentynyl)-5-allylbarbituric acid sodium salt
A809228
AC1L1S67
AC1Q1VYK
ACT02624
alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid
Alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituricacid
AN-44028
API0009096
Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-
Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, (.+/-.)-
Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, sodium deriv
Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, sodium deriv.
Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, sodium salt
Brevimytal
Brevital
Brevital (TN)
Brevital sodium (TN)
Brietal
Brietal sodique
Brietal sodium
C-16395
C07844
CC-30270
CCRIS 4716
CHEBI:102216
CHEBI:6834
CHEMBL30219
CHEMBL7413
Compound 22451
Compound 25398
CTK6C6110
D00712
D04985
D0S8TD
DB00474
DEA No. 2264
DR000774
DTXSID1023287
DTXSID6026036
EINECS 205-798-6
EINECS 206-217-9
Enallynymal sodium
Enallynymall
Enallynymalum
Epitope ID:117125
FT-0603359
GTPL7233
HE057938
HE152582
HE326184
Lilly 22451
LS-173735
LS-185012
LS-23773
LS-23774
LS-23775
LS-23776
LS-23777
Methodrexitone
METHOHEXITAL
Methohexital (USP/INN)
Methohexital [USP:INN:BAN]
Methohexital 1.0 mg/ml in Methanol
Methohexital sodium
Methohexital sodium (USP)
Methohexital Sodium [USAN]
Methohexital, Monosodium Salt
methohexitalsodium
Methohexitalum
Methohexitalum [INN-Latin]
Methohexitone
Methohexitone sodium
Metoesital
Metoesital [DCIT]
Metohexital
Metohexital [INN-Spanish]
NZXKDOXHBHYTKP-UHFFFAOYSA-N
SCHEMBL203151
SCHEMBL5115660
SCHEMBL80729
sodium 5-(hex-3-yn-2-yl)-1-methyl-4,6-dioxo-5-(prop-2-en-1-yl)-1,4,5,6-tetrahydropyrimidin-2-olate
SODIUM 5-(HEX-3-YN-2-YL)-3-METHYL-2,4,6-TRIOXO-5-(PROP-2-EN-1-YL)-1,3-DIAZINAN-1-IDE
sodium 5-allyl-1-methyl-5-(1-methyl-2- pentynyl)barbiturate
Sodium 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)barbiturate
sodium 5-allyl-1-methyl-5-(1-methylpent-2-yn-1-yl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-olate
SODIUM METHOHEXITAL
Sodium methohexitone
Sodium-dl-5-allyl-1-methyl-5-(1-methyl-2-pentynyl)barbiturate
VA11279

US Patents and Regulatory Information for BREVITAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products BREVITAL SODIUM methohexital sodium INJECTABLE;INJECTION 011559-004 Dec 21, 2012 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Argus Health
Julphar
Healthtrust
UBS
Accenture
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.